Successful treatment of infantile hemangiomas with interferon-α-2b

Journal of Pediatric Hematology/Oncology

Volumn 19, Issue 3, 1997, Pages 237-244

  Chang, Eugenia ^a   Boyd, Anne ^a   Nelson, Christine C ^a   Crowley, Dennis ^a   Law, Terence ^b   Keough, Karen M ^b   Folkman, Judah ^b   Ezekowitz, R Alan B ^c   Castle, Valerie P ^a,d  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Basic fibroblast growth factor; Hemangioma; Idiopathic hypertrophic subaortic stenosis; Interferon alpha 2b; Therapy

Indexed keywords

ALPHA2B INTERFERON; BASIC FIBROBLAST GROWTH FACTOR; BETAMETHASONE; CORTICOSTEROID; FUROSEMIDE; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; TRIAMCINOLONE ACETONIDE;

ARTICLE; BLOOD CLOTTING DISORDER; CANCER IMMUNOTHERAPY; CASE REPORT; CONGESTIVE HEART FAILURE; FEMALE; HEMANGIOMA; HUMAN; INFANT; LEUKOCYTOSIS; LIVER TOXICITY; MALE; MOTOR DYSFUNCTION; NEWBORN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

EXOPHTHALMOS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEMANGIOMA; HUMANS; INFANT; INTERFERON ALFA-2B; MAGNETIC RESONANCE IMAGING; MALE; ORBITAL NEOPLASMS; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031007341     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199705000-00011     Document Type: Article

References (41)

1. Pratt GA. Birthmarks in infants. Arch Dermatol 1953;67:302-5.
2. Hohmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatr 1955;44:370-9.
3. Bowers RE, Graham EA, Tominson KM. The natural history of the strawberry nevus. Arch Dermatol 1960;82:667-70.
4. Mulliken JB, Young A, eds. Vascular Birthmarks: Hemangiomas and Malformation. Philadelphia: W.B. Saunders, 1988.
5. Ryan TJ, Cherry GW, eds. Vascular Birthmarks: Pathogenesis and Management. Oxford: Oxford Publications, 1987.
6. Brown SH, Neerhout RC, Fonkalsrud EW. Prednisone therapy in the management of large hemangiomas in infants and children. Surgery 1972;71:168-73.
7. Weber TR, Connors RH, Tacey TF, et al. Complex hemangiomas of infants and children. Arch Surg 1990;125:1017-21.
8. Enjoiras O, Riche MC, Merland JJ, et al. Management of alarming hemangiomas in infancy: A review of 25 cases. Pediatrics 1990;85(4):491-98.
9. Bell AJ, Chisholm M, Hickton M. Reversal of coagulapathy in Kasabach Merritt Syndrome with transexamic acid. Scand J Haematol 1986;37:249-52.
10. Shulkin B, Argenta L, Cho KJ, et al. Kasabach Merritt Syndrome: Treatment with epsilon aminocaproic acid; assessment by Indium III Platelet Scintography. J Pediatr 1990;117(5):746-9.
11. Woods JE. Extended use of sodium tetradecyl sulfate in treatment of hemangiomas and other related conditions. Plast Reconstr Surg 1987;79(4):542-9.
12. Sato Y, Frey EE, Wicklund B, et al. Embolization therapy in the management of infantile hemangioma with Kasabach Merritt Syndrome. Pediatr Radiol 1987;17:503-4.
13. Orchard PJ, Smith CM, Woods WG, et al. Treatment of hemangioendotheliomas with alpha interferon. Lancet 1989;2:565-7.
14. Takahashi K, Mulliken JB, Kozakewich HPW, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;92:2357-64.
15. Teillac-Hamel D, De Prost Y, Bodemer C, et al. Serious childhood angiomas: Unsuccessful alpha-2b interferon treatment: A report of four cases. Br J Dermatol 1993;129:473-6.
16. Loughnan MS, Elder J, Kemp A. Treatment of a massive orbitalcapillary hemangioma with interferon alpha 2b: Short-term results. Arch Ophthalmol 1992;110:1366-7.
17. Mortureux P, Pedespan JM, Greselle JF, et al. Traitement d'un hemangiome cervicofacial grave par interferon alpha-2b. Arch Pediatr 1995;2:237-40.
18. Illum N, Karlsmark T, Svejgaard E, et al. Ulcerated haemangioma successfully treated with interferon alfa-2b and topical granulocyte-macrophage colony-stimulating factor. Dermatology 1995;191:315-7.
19. White C. Treatment of hemangiomatosis with recombinant interferon alfa. Semin Hematol 1990;27(3, Suppl 4):15-22.
20. Ezekowitz RAB, Mulliken J, Folkman J. Interferon alpha-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326(22):1456-63.
21. Ohlms LA, McGill TJ, Jones DT, et al. Interferon alpha 2a therapy for airway hemangiomas. Ann Otol Rhinol Laryngol 1994;103:1-8.
22. Rothe MJ, Rowse D, Grant-Kels JM. Benign neonatal hemangiomatosis with aggressive growth of cutaneous lesions. Pediatr Dermatol 1991;8(2):140-6.
23. Ricketts RR, Hatley RM, Corden BJ, et al. Interferon alpha 2a for the treatment of complex hemangiomas of infancy and childhood. Ann Surg 1994;219(6):605-14.
24. Hatley RM, Sabio H, Howell CG, et al. Successful management of an infant with a giant hemangioma of the retroperitoneum and Kasabach-Merritt Syndrome with alpha-interferon. J Pediatr Surg 1993;28(10):1356-9.
25. MacArthur CJ, Senders CW, Katz J. The use of interferon alfa-2a for life-threatening hemangiomas. Arch Otolaryngol Head Neck Surg 1995;121:690-3.
26. Rosenthal G, Snir M, Biedner B. Corticosteroid resistant orbital hemangioma with proptosis treated with interferon alfa-2-a and partial tarsorrhaphy. J Pediatr Ophthalmol Strabismus 1995;32:50-1.
27. Klein C, Hauser M, Hadorn HB. Interferon alpha-2a therapy of consumptive coagulapathy in Kasabach-Merritt Syndrome. Eur J Pediatr 1992;15:919.
28. Blei F, Orlow SJ, Geronemus RG. Supraumbilical midabdominal raphe, sternal atresia, and hemangioma in an infant: Response of hemangioma to laser and interferon alfa-2a. Pediatr Dermatol 1993;10(1):71-6.
29. Blei F, Orlow SJ, Geronemus RG. Interferon alfa-2a therapy for extensive perianal and lower extremity hemangioma. J Am Acad Dermatol 1993;29(1):98-9.
30. Chiu HH, Chen RL, Lin KH, et al. Recombinant alpha-interferon treatment of intracranial hemangioma and Kasabach-Merritt Syndrome in an infant with cytomegalovirus. J Formos Med Assoc 1995;94(5):261-6.
31. Suarez M, Pensler JM, Paller AS. Response of a deep tufted angioma to interferon alfa. J Am Acad Dermatol 1995;33(1):124-6.
32. Spiller JC, Sharma, V, Woods GM, et al. Diffuse neonatal hemangiomatosis treated successfully with interferon alpha 2a. J Am Acad Dermatol 1992;27(12):102-4.
33. Deb G, Donfrancesco A, Desio L, et al. Treatment of hemangiomas of infancy and babies with interferon alfa-2a: Preliminary results. International Journal of Pediatric Hematology/Oncology 1996;3:109-13.
34. Barlow CF, Priebe CJ, Mulliken JB, et al. Adverse effects of interferon alfa-2a in the treatment of hemangiomas of infancy on the early development of the central nervous system: A preliminary report. J Pediatr, in press.
35. Bobele GB, Ward KE, Bodenstein JB. Hypertrophic cardiomyopathy during corticotropin therapy for infantile spasms. A clinical and echocardiographic study. Am Dis in Child 1993;147(2):223-5.
36. Riggs T, Hirschfeld S, Rajai H. The pediatric spectrum of dynamic left ventricular outflow obstruction. Am Heart J 1980;99(3):301-9.
37. Israel BA, Sherman FS, Guthrie RD. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants. Am J Perinatol 1993;10(11):307-10.
38. Montesano R, Vassalli JD, Baird A, et al. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A 1986;83:7297-301.
39. Soutter AD, Ngyuen M, Watanabe H, et al. Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. Cancer Res 1993;53(21):5297-9.
40. Ngyuen M, Wanatabe H, Budson AC, et al. Increased levels of angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancer. J Natl Cancer Inst 1994;86(5)356-61.
41. Goldberg NS, Rosanova MA. Periorbital hemagiomas. Dermatol Clin 1992;10(4):653-60.